Our portfolio company GenomSys, a Swiss startup specializing in DNA data processing software, is preparing to introduce a variant caller and an annotation pipeline that will allow individuals to control and share their own genomic sequences with clinicians and researchers. The technology will be available both through a web portal and a mobile app for which the firm will pursue CE marking as an in vitro diagnostic tool.

A new CEO with digital health experience, Alessio Ascari, is guiding the Lausanne, Switzerland-based company through the launch.While this is his first true job in genomics, Ascari, who actually joined the company in September, has a long history as a management consultant in digital health and therapeutics, most recently as head of his own consulting firm.

Read the full article on Genomeweb website here.